- Home
- FSP vs CMPX Comparison
FSP vs CMPX Comparison
Compare FSP & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSP
- CMPX
- Stock Information
- Founded
- FSP 1981
- CMPX 2014
- Country
- FSP United States
- CMPX United States
- Employees
- FSP N/A
- CMPX N/A
- Industry
- FSP Real Estate Investment Trusts
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- FSP Real Estate
- CMPX Health Care
- Exchange
- FSP Nasdaq
- CMPX Nasdaq
- Market Cap
- FSP 199.9M
- CMPX 236.7M
- IPO Year
- FSP N/A
- CMPX N/A
- Fundamental
- Price
- FSP $1.94
- CMPX $1.38
- Analyst Decision
- FSP
- CMPX Strong Buy
- Analyst Count
- FSP 0
- CMPX 3
- Target Price
- FSP N/A
- CMPX $7.67
- AVG Volume (30 Days)
- FSP 456.3K
- CMPX 503.1K
- Earning Date
- FSP 10-29-2024
- CMPX 11-12-2024
- Dividend Yield
- FSP 2.04%
- CMPX N/A
- EPS Growth
- FSP N/A
- CMPX N/A
- EPS
- FSP N/A
- CMPX N/A
- Revenue
- FSP $126,508,000.00
- CMPX $850,000.00
- Revenue This Year
- FSP N/A
- CMPX N/A
- Revenue Next Year
- FSP $0.02
- CMPX $747.71
- P/E Ratio
- FSP N/A
- CMPX N/A
- Revenue Growth
- FSP N/A
- CMPX N/A
- 52 Week Low
- FSP $1.47
- CMPX $0.77
- 52 Week High
- FSP $2.72
- CMPX $2.34
- Technical
- Relative Strength Index (RSI)
- FSP 58.74
- CMPX 34.67
- Support Level
- FSP $1.78
- CMPX $1.27
- Resistance Level
- FSP $1.89
- CMPX $1.46
- Average True Range (ATR)
- FSP 0.08
- CMPX 0.14
- MACD
- FSP -0.01
- CMPX -0.05
- Stochastic Oscillator
- FSP 80.00
- CMPX 15.07
About FSP Franklin Street Properties Corp.
Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The company's operations include rental income from real estate leasing, interest income from secured loans made on office properties, property dispositions, and fee income from asset/property management and development. Franklin Street markets Atlanta, Dallas, Denver, Houston, and Minneapolis.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.